 CHESTERBROOK, Pa., May 18, 2022 GLOBE NEWSWIRE -- Trevena, Inc. Nasdaq: TRVN, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system CNS disorders, today announced that Carrie Bourdow, President CEO and Barry Shin, CFO, will be participating in the H.C. Wainwright Global Investment Conference being held May 23 - 26, 2022. 